# ZEMDRI
> **NDA210303** · New Drug Application · Sponsor: CIPLA USA · Approved 2018-06-25
## Drug
- **FDA Application Number:** NDA210303
- **Application type:** New Drug Application
- **Brand name:** ZEMDRI
- **Generic name:** PLAZOMICIN
- **Active ingredients:** PLAZOMICIN SULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CIPLA USA
- **Manufacturer:** Cipla Therapeutics Inc.
- **First approval:** 2018-06-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210303)
---
*AI Analytics · CC0 1.0*